Giuseppe Di Lucca - Concepedia

Author

Giuseppe Di Lucca

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Di Lucca, Giuseppe, G Di Lucca, G Lucca, G. Di Lucca, G.DI. Lucca, Giuseppe Di Lorenzo, Giuseppe Di Lucca, Giuseppe di Lucca, Lucca G, Patrizia Rovere-Querini

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Vita-Salute San Raffaele University Fondazione IRCCS Istituto Nazionale dei Tumori IRCCS Ospedale San Raffaele Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

About

Giuseppe Di Lucca is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	322
2	Engineering	2	2	932
3	Public Health	1	1	912
4	Environmental Engineering	1	1	912
5	Gastroenterology	1	1	89

Giuseppe Di Lucca

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, The Lancet Rheumatology	2020	991
Effects of environmental factors and agricultural techniques on antioxidantcontent of tomatoes Yvon Dumas, M. Dadomo, Giuseppe Di Lucca, Journal of the Science of Food and Agriculture NutritionAgricultural TechniquesEngineeringAgricultural EconomicsCrop Quality	2003	912
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial Michele Reni, Stefano Cereda, Michèle Milella, European Journal of Cancer Pancreatic CancerPhase IiGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaMedicine	2013	90
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo, Annals of Oncology Surgical OncologyOncologyGastrointestinal OncologyMedicineFolinic Acid	2014	89
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, The Lancet Oncology Endocrine OncologyBreast OncologyMedicinePharmacologyEndocrine-sensitive Breast Cancer	2018	86
Prognostic Factors for Survival inMetastatic Renal Cell Carcinoma:Retrospective Analysis from109 Consecutive Patients Giovanni Citterio, Alexia Bertuzzi, Moreno Tresoldi, European Urology	1997	70
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19 Simin Aysel Florescu, Mihaela Zaharia, Alma Kosa, JAMA	2023	66
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients Diego Palumbo, Alberto Zangrillo, Alessandro Belletti, Journal of Critical Care Radiological PredictorRespiratory DiseasesPneumothoraxInfectious Respiratory DiseaseThoracic Surgery	2021	35
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19 Stefania Calvisi, Giuseppe A. Ramirez, Marina Scavini, Metabolism	2021	33
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon C Besana, A Borri, Eugênio Bucci, European Journal of Cancer UrologyGenitourinary CancerMedicineImmunologyRenal Inflammation	1994	22

Page 1